Yumrukaya, L.; Hagens, A.; İnkaya, A.Ç.; Metan, G.; Postma, M.; Yeğenoğlu, S.; Akova, M.
Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis. Antibiotics 2025, 14, 653.
https://doi.org/10.3390/antibiotics14070653
AMA Style
Yumrukaya L, Hagens A, İnkaya AÇ, Metan G, Postma M, Yeğenoğlu S, Akova M.
Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis. Antibiotics. 2025; 14(7):653.
https://doi.org/10.3390/antibiotics14070653
Chicago/Turabian Style
Yumrukaya, Leyla, Arnold Hagens, Ahmet Çağkan İnkaya, Gökhan Metan, Maarten Postma, Selen Yeğenoğlu, and Murat Akova.
2025. "Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis" Antibiotics 14, no. 7: 653.
https://doi.org/10.3390/antibiotics14070653
APA Style
Yumrukaya, L., Hagens, A., İnkaya, A. Ç., Metan, G., Postma, M., Yeğenoğlu, S., & Akova, M.
(2025). Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis. Antibiotics, 14(7), 653.
https://doi.org/10.3390/antibiotics14070653
